References
- Conway PH, Clancy C. Comparative-effectiveness research—implications of the federal coordinating council’s report. N Engl J Med. 2009;361:328–30.
- Haynes B. Can it work? Does it work? Is it worth it? The testing of healthcareinterventions is evolving. Bmj. 1999;319:652
- Eichler HG, Baird LG, Barker R, Bloechl-Daum B, Børlum-Kristensen F, Brown J, et al. From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients. Clin Pharmacol Ther. 2015;97:234–46.
- Sherman RE, Anderson SA, Dal Pan GJ, Gray GW, Gross T, Hunter NL, et al. Real-world Evidence - What Is It and What Can It Tell Us? N Engl J Med. 2016;375:2293–7.
- European Medicines Agency (EMA). Annual Report 2017 [Internet]. [cited 2018 Jun 1]; Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Annual_report/2018/04/WC500248201.pdf
- Tandvårds- och läkemedelsförmånsverket (TLV). Mesta möjliga hälsa för skattepengarna [Internet]. [cited 2018 Jun 1] Available from: https://www.tlv.se/om-oss/press/nyheter/arkiv/2018-02-22-mesta-mojliga-halsa-for-skattepengarna.html
- Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24:659–67.
- Anell A. The public-private pendulum-patient choice and equity in Sweden. N Engl J Med. 2015;372:1–4.
- WHO Classifications [Internet. ]. [cited 2017 ;Sep 14]; Available from: http://www.who.int/classifications/icd/en/
- NOMESCO NOMESCO Classification of Surgical Procedures [Internet. ]. 2010 [Cited 2017 ;Sep 14]; Available from: https://norden.diva-portal.org/smash/get/diva2:970547/FULLTEXT01.pdf
- WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2017 [Internet]. [Cited 2018 ;Feb 5]; Available from: https://www.whocc.no/
- Ferrer P, Ballarín E, Sabaté M, Laporte J-R, Schoonen M, Rottenkolber M, et al. Sources of European drug consumption data at a country level. Int J Public Health. 2014;59:877–87.
- Larsen MD, Cars T, Hallas J. A minireview of the use of hospital-based databases in observational inpatient studies of drugs. Basic Clin Pharmacol Toxicol. 2013;112:13–8.
- Jerlvall L, Pehrson T. eHälsa i landstingen (In Swedish) [Internet. ]. 2012 [Cited 2018 ;Jan 15]; Available from: https://www.inera.se/globalassets/om-inera/styrdokument-och-rapporter/ehalsa-i-landstingen/ehlsa_i_landstingen_slit_2012.pdf
- Jerlvall L, Pehrsson T. eHälsa och IT i landstingen [Internet. ]. [cited 2018 ;Jun 1]; Available from: https://www.inera.se/globalassets/om-inera/styrdokument-och-rapporter/ehalsa-i-landstingen/ehalsa-it-ilandstingen-2017.pdf
- Cars T. Real-time monitoring of healthcare interventions in routine care: effectiveness and safety of newly introduced medicines [Internet. ]. 2016 [Cited 2018 ;Jan 15]; Available from: http://uu.diva-portal.org/smash/get/diva2:1015130/FULLTEXT01.pdf
- Hernán MA, Robins JM. Causal inference book [Internet]. Boca Raton: Chapman & Hall/CRC, forthcoming, 2018. Available from. https://www.hsph.harvard.edu/miguel-hernan/causal-inference-book/
- Hernán MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183:758–64.
- Textor J, Hardt J, Knuppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011;22:745
- Schneeweiss S, Gagne JJ, Glynn RJ, Ruhl M, Rassen JA. Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development. Clin Pharmacol Ther. 2011;90:777–90.
- Stürmer T, Wyss R, Glynn RJ, Brookhart MA. Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med. 2014;275:570–80.
- Cars T, Lindhagen L, Malmström R, Neovius M, Schwieler J, Wettermark B, et al. Effectiveness of drugs in routine care: a model for sequential monitoring of new medicines using dronedarone as example. Clin Pharmacol Ther. 2018;103:493–501.
- ENCePP. E-Register of Studies [Internet. ]. [cited 2018 ;Jun 1]; Available from: http://www.encepp.eu/encepp_studies/e_register.html
- Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41–55.
- Austin PC. Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score. Pharmacoepidem Drug Safe. 2008;17:1202–17.
- Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998;54:948–63.